Page last updated: 2024-08-16

troglitazone and ly 171883

troglitazone has been researched along with ly 171883 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Fukumoto, S; Hosoi, M; Koyama, H; Morii, H; Nishizawa, Y; Tanaka, S; Yamakawa, K1

Other Studies

2 other study(ies) available for troglitazone and ly 171883

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.
    Biochemical and biophysical research communications, 2000, May-19, Volume: 271, Issue:3

    Topics: Acetophenones; Cells, Cultured; Chromans; Endothelial Growth Factors; Gene Expression Regulation; Humans; Lymphokines; Muscle, Smooth, Vascular; Peroxisome Proliferators; Pioglitazone; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetrazoles; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilator Agents

2000